essential oil of psidium cattleianum leaves: antioxidant and antifungal...
TRANSCRIPT
http://informahealthcare.com/phbISSN 1388-0209 print/ISSN 1744-5116 online
Editor-in-Chief: John M. PezzutoPharm Biol, Early Online: 1–9
! 2014 Informa Healthcare USA, Inc. DOI: 10.3109/13880209.2014.914231
ORIGINAL ARTICLE
Essential oil of Psidium cattleianum leaves: Antioxidant andantifungal activity
Micheli R. Castro1, Francine N. Victoria1,2, Daniela H. Oliveira1, Raquel G. Jacob1, Lucielli Savegnago2, andDiego Alves1
1Laboratorio de Sıntese Organica Limpa, CCQFA, Universidade Federal de Pelotas, Pelotas-RS, Brazil and 2Centro de Desenvolvimento Tecnologico,
Unidade Biotecnologia, Universidade Federal de Pelotas, Grupo de Pesquisa em Neurobiotecnologia, Pelotas-RS, Brazil
Abstract
Context: Psidium cattleianum Sabine (Myrtacea) is rich in vitamin C and phenolic compounds,including epicatechin and gallic acid as the main components.Objective: To evaluate the antifungal and antioxidant capacity in vitro of the essential oil ofaraca (EOA). The acute toxicity of the EOA also was evaluated in mice.Materials and methods: The leaves of the P. cattleianum were extracted by steam distillation.The antioxidant capacity was evaluated by in vitro tests [1,1-diphenyl-2-picryl-hydrazyl (DPPH),2,2-azinobis(3-ethylbenzothiazoline-6-sulfonate) (ABTS), ferric ion reducing antioxidant power(FRAP), linoleic acid oxidation, thiobarbituric acid reactive species (TBARS)], and ex vivo analysis[TBARS, d-aminulevunilate dehydratase (d-Ala-D) and catalase activity, non-protein thiols(NPSH), and ascorbic acid levels]. The toxicity was studied in mice by a single oraladministration of EOA; and the antifungal activity was performed with five strains of fungi.Results: The EOA exhibited antioxidant activity in the FRAP assay and reduced lipidperoxidation in the cortex (Imax¼ 32.90 ± 2.62%), hippocampus (IC50¼ 48.00 ± 3.00 mg/ml andImax¼ 32.90 ± 2.62%), and cerebellum (Imax¼ 45.40 ± 14.04%) of mice. Acute administration ofthe EOA by the oral route did not cause toxicological effects in mice (LD504500mg/ml). TheEOA also showed antifungal activity through of the determination minimum inhibitoryconcentration (MIC) values ranging from 41.67 ± 18.04 to 166.70 ± 72.17 mg/ml for tested strains.Conclusion: The results of present study indicate that EOA possess antioxidant properties,antifungal and not cause toxicity at tested doses.
Keywords
Araca, oxidative stress, toxicology
History
Received 20 January 2014Revised 28 March 2014Accepted 8 April 2014Published online 24 November 2014
Introduction
Psidium cattleianum Sabine (Myrtacea) is known as straw-
berry guava or araca. The fruits have white pulp and a tart
taste, and are rich in vitamin C (Lapcik et al., 2005; Luximon-
Ramma et al., 2003; Pino et al., 2001) and contain a large
amount of phenolic compounds including epicatechin and
gallic acid as the main components (Medina et al., 2011).
Natural antioxidants are in high demand for bio-
pharmaceuticals application in several fields of study.
In fact, intensive research has been performed for the
extraction, characterization, and utilization of natural prod-
ucts/antioxidants, like essential oils (EOs) and plant extracts,
which may serve as potent candidates in combating the
oxidative-related pathologies (Ozen et al., 2011).
In this sense, EOs are aromatic oily liquids obtained from
plant material, like flowers, buds, seeds, leaves, twigs, bark,
herbs, wood, fruits, and roots (Bakkali et al., 2008). The
percentage of the chemical components of EOs varies among
species and plants parts. These components are chemically
derived from terpenes and their oxygenated derivatives
(Solorzano-Santos & Miranda-Novales, 2012). EO possesses
many pharmacological effects described, such as antioxidant
(Victoria et al., 2012; Wang et al., 2013), antimicrobial (Singh
et al., 2013; Stefanakis et al., 2013), and antinociceptive
(Amorim et al., 2009).
In the context of natural products biological potential, the
antioxidant potential of native fruits from the southern of Rio
Grande do Sul, Brazil, such as ‘‘araca’’ (Psidium cattleianum)
have been studied (Alvarenga et al., 2013; Pereira et al.,
2013).
Araca, with yellow or red berries, has a nice balance
between soluble solids and acidity, and ripens in Brazil in late
summer between February and May (Drehmer & Amarante,
2008). Preliminary exploratory studies suggested high anti-
oxidant activity and high phenolic content differing among
araca genotypes (Medina et al., 2011). The few investigations
of araca suggest nutritional and functional potential
Correspondence: Lucielli Savegnago, Centro de DesenvolvimentoTecnologico, Unidade Biotecnologia, Universidade Federal de Pelotas,Grupo de Pesquisa em Neurobiotecnologia, Pelotas-RS, Brazil; DiegoAlves, Laboratorio de Sıntese Organica Limpa, CCQFA, UniversidadeFederal de Pelotas, CEP 96010-900, Pelotas-RS, Brazil. E-mail:[email protected]
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
(Galho et al., 2007). Although traditionally appreciated for its
sensory attributes and expected functional properties, araca is
still poorly characterized, and limited scientific information is
available about the fruit.
Few studies were performed with the leaves of araca.
Alvarenga et al. (2013) evaluated the in vivo analgesic and
toxicity of a hydroalcoholic extract from P. cattleianum, the
results demonstrated that extract demonstrated strong anal-
gesic activity and no toxicity in cultures of LLC-MK2
mammalian fibroblast cells. Aqueous extract of P. cattleia-
num leaves reduced enamel demineralization, acidogenic
potential, microorganism viability, and extracellular polysac-
charide production (Brighenti et al., 2012), and a chloroform
leaf extract activated specific intracellular death-related
pathways, leading to caspase-3 activation and induction of
apoptosis in SNU-16 cells (Moona et al., 2012).
Taken together the potential of EOs and araca, and the
experience of our research group in the search for new
biologically active compounds, the aim of this study was to
evaluate the chemical composition of EO from the leaves of
araca (EOA), the antioxidant effects and analyze whether it
caused acute toxicity when orally administered to mice.
Additionally, studies were performed to evaluate the anti-
fungal activity of EOA against fungal strains.
Materials and methods
Animals
Adult male Swiss mice (25–35 g) were used. The mice were
kept in separate animal rooms on a 12 h light/dark cycle at a
temperature of 22 ± 2 �C and with free access to food and
water. The mice were treated according to the guidelines of
the Committee on Care and Use of Experimental Animal
Resources of the Federal University of Pelotas, Pelotas, Brazil
(CEEA 2762).
Plant material and EO material
The leaves of the P. cattleianum red plant were collected from
a research orchard (germplasm collection of Embrapa Clima
Temperado, Pelotas, RS, Brazil) in February and March 2012
in the morning (voucher specimen PEL no. 26.320). EOA was
extracted by steam distillation. The fresh leaves (600 g) were
cut with scissors into small pieces and put in a 2000 ml
reaction flask. After 3 h of extraction, the organic phase was
separated and dried over Na2SO4. The distillations were
performed in triplicate to determine the yield. The chemical
composition of the crude EO was evaluated using gas
chromatography coupled with mass spectrometry (GC–MS).
Analysis of the EOA
The identification and determination of the major chemical
constituent ratio of EOA were performed by GC–MS. The oil
was dissolved in hexane, and the injected sample volume was
1.0ml. A Shimadzu GC–MS QP2010 (Tokyo, Japan) and a
polyethylene glycol (Carbowax), model Rtx-Wax (RESTEC)
(30 m� 0.25 mm i.d., film thickness 0.25mm) capillary
column were used for the analysis. The temperature was
first held at 40 �C, and then raised to 250 �C (10 min, 20� C/
min). The carrier gas was helium at a flow rate of 3 ml/min.
The components of the oil were identified based on the
comparison of their retention indices and mass spectra with
the fragmentation patterns from computer matching with the
NIST/EPA/NIH/2005 library.
Determination of in vitro antioxidant activity of EOA
The EOA was diluted in dimethyl sulfoxide (DMSO) for the
in vitro studies. The DPPH radical is a stable free radical
commonly used as a substrate to evaluate in vitro antioxidant
activity. Radical-scavenging activity was determined by the
reaction of the stable DPPH radical with the compounds, in
accordance with the method with some modifications
(Choi et al., 2002). Different concentrations of EOA (10–
500 mg/ml) were mixed with a methanol solution containing
the DPPH radical. The mixture was incubated for 30 min at
30 �C, and the absorbance was measured at 517 nm. The
values are expressed as the percentage of inhibition of DPPH
absorbance (% inhibition) in relation to the control values
without the EO.
ABTS radical scavenging activity was determined accord-
ing to the method described by Re et al. (1999) with some
modifications. ABTSS+ was produced by react the
ABTS stock solution with 2.45 mM potassium persulfate
(final concentration) and allowing the mixture to stand in the
dark at room temperature for 12–16 h before use. For the
study of samples, the ABTSS+ stock solution was diluted
with phosphate-buffered saline (5 mM, pH 7.4) to an absorb-
ance of 0.70 at 0.73 nm. Different concentrations of EOA
(10–50 mg/ml) were mixed with ABTSS+ solution, and
the mixture was left to stand for 30 min at 30 �C; the
absorbance was measured at 734 nm. The values are
expressed as the percentage of inhibition of ABTSS+
absorbance (% inhibition) in relation to the control values
without compound.
The ferric ion (Fe3+) reducing antioxidant power (FRAP)
method was used to measure the reducing capacity of EOA.
The FRAP assay was carried out as described by Stratil et al.
(2006). The FRAP reagent was prepared by mixing 38 mM
anhydrous sodium acetate in distilled water (pH 3.8), 20 mM
FeCl3�6H2O in distilled water, and 10 mM 2,4,6-
tri(2-pyridyl)-S-triazine (TPTZ) in 40 mM HCl in proportions
of 10:1:1. This reagent was freshly prepared before each
experiment. Different concentrations of EOA and FRAP
reagent were added to each sample, and the mixture was
incubated at 37 �C for 40 min in the dark. The absorbance of
the resulting solution was measured at 593 nm by a
spectrophotometer.
The capacity of EOA to reduce lipid peroxidation was
evaluated by three methods: linoleic acid oxidation, lipid
peroxidation induced by sodium nitroprusside (SNP) in
regions of mouse brain (cortex, hippocampus, and cerebel-
lum), and basal lipid peroxidation in liver, kidney, and brain
of mice.
The linoleic acid peroxidation assay was based on the
reaction mixture contained linoleic acid (48.8 mM), Tris-HCl
(100 mM, pH 7.5), SNP (100 mM), and a varying concentra-
tions of EOA (10–500 mg/ml). The reaction was initiated
by the addition of SNP, incubated for 30 min at 37 �C,
and terminated by the addition of trichloroacetic acid
2 M. R. Castro et al. Pharm Biol, Early Online: 1–9
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
(TCA, 5.5%). An aliquot of 250 mL of thiobarbituric acid
(TBA, 1%) in 50 mM NaOH was added to 250 of the reaction
mixture, followed by heating (90 �C) for 10 min, after this
time, the organic phase was extracted with 500 mL of butanol
(PA) and centrifuged at 3500g for 10 min and the absorbance
of thiobarbituric acid-reacting substances (TBARS) in the
supernatant was read at 532 nm and converted into the
percentage oxidation (Choi et al., 2002).
To evaluate the effect of EOA in lipid peroxidation in
tissue of mice, the animals were euthanized, and the hepatic,
renal, and cerebral tissues were rapidly removed and placed
on ice and the brain regions were dissected. All tissues were
kept chilled and homogenized in 50 mM Tris-HCl at
pH 7.4 (liver and kidney (1/10) and brain and brain regions
(1/5), weight/volume [w/v]). The homogenate was centrifuged
for 10 min at 2400 rpm to yield a pellet that was discarded and
a low-speed supernatant (S1) for each tissue, which was
used for SNP-induced lipid peroxidation and basal lipid
peroxidation.
Lipid peroxidation in the cortex, hippocampus, and
cerebellum was performed by the formation of TBARS
during an acid-heating reaction as previously described by
Ohkawa et al. (1979). A 20 ml aliquot of the cortex and
cerebellum (S1) and a 10 ml aliquot of the hippocampus S1
were pre-incubated in the presence of EOA (1–500 mg/ml)
with and without SNP (100 mM) for 1 h at 37 �C. The mixture
was then incubated with sodium dodecyl sulfate (SDS, 8.1%),
TBA (0.8%), and acetic acid/HCl (pH 3.4) at 95 �C for 2 h.
Malondialdehyde (MDA) was used as a biomarker of fatty-
acid peroxidation. The absorbance of the sample was
measured at 532 nm, and the results are expressed as
percentage of lipid peroxidation.
To extend the studies about the antioxidant potential of the
EOA, its effect on the in vitro basal lipid peroxidation on
liver, kidney, and brain was evaluated according to the
methodology of Ohkawa et al. (1979). An aliquot of 200 ml of
S1 was pre-incubated for 1 h at 37 �C with different concen-
trations of EOA (10–500 mg/ml) or vehicle (DMSO). The
mixture was then incubated with SDS (8.1%), TBA (0.8%),
and acetic acid/HCl (pH 3.4) at 95 �C for 2 h. MDA was used
as a biomarker of lipid peroxidation and the results are
expressed as % of lipid peroxidation.
In vivo experiments
Acute toxicity
To investigate the potential acute toxicity caused by the EOA,
the mice received a single oral dose of the EOA (100, 200,
and 500 mg/kg) or a vehicle (10 ml/kg of canola oil). After
administration, the animals were observed for up to 72 h
(at the interval of 24 h) to determine the lethal dose (LD50).
Body weight gain was recorded as a sign of general
toxicity. After 72 h of exposure, the mice were euthanized
by cervical displacement, and the brain, liver, and kidney
were removed, homogenized (liver and kidney 1/10 v/v and
brain 1/5 v/v), and centrifuged. The S1 was separated and used
for analysis of TBARS, ascorbic acid, and non-protein thiols
(NPSH) levels as well as the (d-aminulevunilate dehydratase)
(d-Ala-D) and catalase activities (see section Analysis of
the EOA).
Ex vivo analysis
Among the lipid peroxidation products used for antioxidant
assays, MDA has been most widely used to evaluate the
antioxidant activity in lipid peroxidation systems. In this
work, MDA formation was used as a marker of lipid
peroxidation according to the method reported by Ohkawa
et al. (1979).
The d-Ala-D was assayed according to the method reported
by Sassa (1982). d-Ala-D is a sulfhydryl-containing enzyme
and numerous metals and other compounds that oxidized
sulfhydryl groups modified its activity.
Catalase (CAT) activity, an enzymatic antioxidant defense,
was assayed spectrophotometrically by the method of Aebi
(1984), which involves monitoring the disappearance of H2O2
in the homogenate at 240 nm. The enzymatic activity was
expressed in units of U CAT/mg protein. Vitamin C, a non-
enzymatic antioxidant defense, determination was performed
as described by Jacques-Silva et al. (2001) with some
modifications. NPSH levels were analyzed by the method of
Ellman (1959).
Protein determination
The protein content of the S1 was measured according to the
method reported by Lowry et al. (1951) using bovine serum
albumin (BSA) as a standard.
Antifungal activity
The antifungal activity of EOA was tested with five
fungal strains: Candida albicans, Candida parapsilosis,
Candida guilhermondii, Candida lipolytica, and
Trichosporon asahii that were obtained from the
Department of Microbiology at the Federal University of
Pelotas. Fungal strains were maintained on potato dextrose
agar (PDA) and subcultured (1% inoculum) in potato dextrose
broth at 35 �C for at least 2–4 d before being used in the
screening assays.
The minimum inhibitory concentration (MIC) of EOA was
determined according to the method of NCCLS (2002).
EOA was tested in concentrations ranging from 500 to
0.85 mg/ml, and the assays were repeated at least three times
in their entirety to confirm the results. The MIC was recorded
as the lowest concentration of EOA that inhibited the fungal
growth.
Statistical analysis
Experimental results were given as the mean ± standard
error (SE) to show variations among groups.
Statistical analyses were performed using one-way ANOVA
followed by the Newman–Keuls multiple comparison test
when appropriate. All in vitro tests were performed at least
three times in duplicate. For the in vivo assays, five to eight
animals were used per group. The IC50 values (concentration
of sample required to inhibit 50% of the effect) were
calculated from the graph of the inhibition percentage
versus the EOA concentration. Differences were considered
statistically significant at a probability of less than 5%
(p50.05).
DOI: 10.3109/13880209.2014.914231 Essential oil of araca 3
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
Results
Chemical composition of EOA
This is the first time that the chemical composition of
EOA of Rio Grande do Sul, Brazil, was investigated,
according to our knowledge. The GC/MS analysis permitted
the identification of 97.5% of the compounds presents in
EOA, with a prevalence of oxygenated sesquiterpenes
(88.13%) followed by non-oxygenated sesquiterpenes
(9.09%) (Figure 1). The major compound found was
isocaryophillene (59.62%).
In vitro assay
As shown in Figure 2(a), EOA exhibited ferric-reducing
ability at concentrations equal and higher than 100 mg/ml.
EOA did not demonstrated effect in the DPPH (electron or
hydrogen-based transfer antioxidant test) and in the ABTS test
(ET-based antioxidant test) (data not shown).
As shown in Figure 2(b), EOA effectively inhibits
SNP-linoleic acid peroxidation at a concentration equal and
higher than 50 mM. EOA presented a value of IC50 of
56.41 ± 5.41 mg/ml and a maximum inhibition of 61.59%.
Figure 3(a) showed that EOA decreased lipid peroxidation
per se at concentrations ranging from of 100 to 500 mg/ml in
the liver, with an IC50 value of 48.00 ± 3.00 mg/ml and Imax of
65.10 ± 11.71%. In the kidney (Figure 3b), EOA decreased
lipid peroxidation at concentrations of 100 and 500 mg/ml
with an Imax value of 32.90 ± 2.62%. In addition, EOA
declined lipid peroxidation in the brain and presented an Imax
of 45.40 ± 14.40%.
Figure 4 shows the effect of EOA on SNP-induced lipid
peroxidation on brain regions. Data demonstrated that SNP
significantly induced lipid peroxidation on the brain struc-
tures. EOA were effective on reducing the SNP-induced lipid
peroxidation at concentrations equal or greater than 10 mg/ml
in hippocampus, cortex and cerebellum. In the cortex, EOA
presented an IC50 value of 8.33 ± 4.04 mg/ml and a maximal
inhibition (Imax) of 80.90 ± 4.00% (4b), in the hippocampus
EOA showed an Imax of 45.87 ± 10.20% (4 a) and in the
cerebellum 28.00 ± 4.40% (Figure 4c).
In vivo assay
Acute toxicity
The oral administration of EOA at doses of 100, 200, and
500 mg/kg did not cause death of any animal. The LD50 value
obtained for the EOA possibly is greater than 500 mg/kg
given that lethality was not observed at this dose.
O
OH HO H
H
HO
α-caryophyllene(6.42%)
naphtalene(1.71%)
azulene(0.96%)
caryophylleneoxide(18.16%)
cadinol(4.63%)
naphtalenol(3.65%)
epiglobulol(2.07%)
isocaryophyllene(59.62%)
A B0
20
40
60
80
100
% o
f com
poun
ds
Figure 1. Chemical composition of the EOA and % of sesquiterpenes oxygenated (A) and not oxygenated sesquiterpenes (B).
4 M. R. Castro et al. Pharm Biol, Early Online: 1–9
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
The administration of EOA at these doses did not cause
significant reduction in the body weight when compared with
the control group (data not shown).
Ex vivo analysis
The levels of TBARS after oral exposure of mice to EOA
were significantly reduced in the liver, kidney at doses 200
and 500 mg/kg, and in the brain at dose of 500 mg/kg
(Figure 5). These data suggest that the EOA does not cause
any oxidative stress in mice tissue after acute treatment,
although it reduces the levels of TBARS in mice liver, kidney,
and brain.
d-Ala-D is a sulfhydryl-containing enzyme that is inhibited
by a variety of sulfhydryl reagents (Folmer et al., 2005).
In this study, the EOA did not alter the enzyme activity in
liver, kidney and brain of mice (data not shown).
C 10 50 100 5000
200
400
600
[μg/ml]
(c)
*
[MD
A]/g
of t
issu
e
Imax = 32.90 ± 2.62 %
C 10 50 100 5000
200
400
600
[μg/ml]
**
(b)
[MD
A]/g
of t
issu
e
IC50 = 48.00 ± 3.00 μg/mlImax = 65.10 ± 11.71 %
Imax = 45.4 ± 14.04 %
C 10 50 100 5000
100
200
300
400
500
600
[μg/ml]
(a)
**
[MD
A]/g
of t
issu
e
Figure 3. Effect of EOA on lipid peroxidation: (a) liver, (b) kidney, and (c) brain. The values are expressed in nmol MDA/g tissue. Data are presentedas mean ± SE (n¼ 5). Asterisks represent a significant effect as compared with the control group (C). *p50.05 by the Student–Newman–Keuls test forpost-hoc comparison.
C 10 50 100 5000.0
0.2
0.4
0.6
0.8
1.0
**
[μg/ml]
(a)
Abs
C 10 50 100 5000
20
40
60
80
100 I
*
**
[μg/ml]
(b) IC50=56.41 μg/ml% Imax = 61.59
% o
xida
tion
Figure 2. Antioxidant activities of the EOA: (a) ferric ion reducing antioxidant power (FRAP). Each value is expressed as the mean ± SE (n¼ 3).Asterisks represent significant *p50.05 when compared with the respective control without essential oil. The values are expressed in absorbance; themean value of absorbance (593 nm) of the control is 0.099 ± 0.004. (b) On the linoleic acid, SNP-induced lipid peroxidation assay. Data are presented asthe mean ± S.E (n¼ 3). The values are expressed as induced percent. The IC50 indicates the necessary concentration to inhibit 50% of lipidperoxidation. The Imax is the maximal inhibition offered by the EO. Asterisks represent significant *p50.05 compared with the induced for SNP-induced sample (100% lipid peroxidation). ANOVA followed by the Newman–Keuls multiple comparison test when appropriate.
DOI: 10.3109/13880209.2014.914231 Essential oil of araca 5
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
C 100 200 5000
500
1000
1500
2000
2500
* *
[mg/kg]
(a)
[MD
A]/
g o
f tis
sue
C 100 200 5000
500
1000
1500
2000
2500
**
[mg/kg]
(b)
[MD
A]/
g o
f tis
sue
C 100 200 5000
500
1000
1500
2000
2500
*
[mg/kg]
(c)
[MD
A]/
g o
f tis
sue
Figure 5. Effect of EOA on lipid peroxidation ex vivo: (a) liver, (b) kidney, and (c) brain. The values are expressed in nmol MDA/g tissue.Data are presented as mean ± SE (n¼ 5). Asterisks represent a significant effect as compared with the control group (C). *p50.05 by theStudent–Newman–Keuls test for post-hoc comparison.
C I 10 50 100 5000
500
1000
1500
2000
2500
* * *
(a)
#
[μg/ml]
[μg/ml]
[μg/ml]
[MD
A]/
g o
f tis
sue
C I 1 10 50 100 5000
500
1000
1500
2000
2500
**
**** **
(b)
#
[MD
A]/
g o
f tis
sue
C I 1 10 50 100 5000
500
1000
1500
2000
2500
* * **
(c)
#
[MD
A]/
g o
f tis
sue
Imax = 45.87 ± % 02.01 IC50 = 8.33 ± 4.04 μg/mlImax = 80.90 ± 4.00 %
Imax = 28.00 ± 4.4 %
Figure 4. Effect of EOA on lipid peroxidation induced by SNP structures brain homogenates: (a) hipocamppus, (b) cortex, and (c) cerebellum.The values are expressed in nmol MDA/g tissue. Data are presented as mean ± SE (n¼ 5). Asterisks represent a significant effect when compared withinduced *p50.05, compared with the SNP-induced sample (100% lipid peroxidation) and # p50.01 compared with the control group (C) by theStudent–Newman–Keuls test for post-hoc comparison.
6 M. R. Castro et al. Pharm Biol, Early Online: 1–9
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
CAT activity was not altered in the liver, kidney, or brain
of mice treated with EOA at any of the tested doses when
compared with the control group. Also, the administration of
EOA did not modified vitamin C levels and NPSH in the liver
and kidney of mice (Table 1).
Antifungal activity
In our study of antifungal activity, EOA presented MIC values
ranging from 41.67 ± 18.04 to 166.70 ± 72.17 mg/ml for the
tested strains (Table 2). To our knowledge, this is the first
report describing the antifungal activity of EOA.
Discussion
Due to the undesirable effects of synthetic compounds, there
has been growing interest in the investigation of natural
products for the discovery of active compounds with
antimicrobial and antioxidant properties that do not have
any negative effects on the human health; one of these natural
additives are the EOs.
In this study, EOA presented an antioxidant effect in the
FRAP, TBARS in vitro (SNP-induced linoleic oxidation,
basal lipid peroxidation in liver, kidney and brain,
SNP-induced brain regions oxidation), and TBARS ex vivo.
Also, EOA did not present any sign of toxicity and did not
alter important oxidative parameters, like d-Ala-D and
catalase activities and vitamin C and NPSH levels.
Furthermore, EOA inhibited significantly the growth of
different clinically important fungal strains.
The chemical compositional analysis of EOA presents the
predominance of non-oxygenated sesquiterpenes and the
major compound found was isocaryophillene (59.62%).
Chalannavar et al. (2013) studied the chemical composition
of the EO of P. cattleianum of South Africa by hydrodistilla-
tion, the analysis revealed caryophyllene oxide as the major
compound, and a predominance of non-oxygenated sesqui-
terpenes (36.78%), corroborating with our findings.
There was a great variability in the chemical composition
of EOs. Such variability depends on several factors including
local climatic and environmental conditions, soil variations,
season, geographical location, geology, the stage of the
vegetative cycle, part of the plant, and the method used to
obtain the EO (Viuda-Martos et al., 2008).
The terpenoid compounds present in the chemical com-
position of EOs are closely associated with their antioxidant
function, mainly due to their redox properties exerted by
various possible mechanisms: free radical-scavenging
activity, hydrogen donors, transition metal chelating activity,
and/or singlet oxygen quenching capacity (Liyana-Pathirana
& Shahidi, 2006). However, the mechanism set in motion by
the antioxidant activity of these compounds is still not clearly
understood. According to Amensour et al. (2009), the
antioxidant activity of EO is believed to be mainly due to
their redox properties, which play an important role in
adsorbing and neutralizing free radicals, quenching singlet
and triplet oxygen, or decomposing peroxides.
In agreement with our results, EOA presented an antioxi-
dant effect in the FRAP assay. The FRAP assay measures the
ability of antioxidant to reduce Fe(III)–triazine complex to
Fe(II)–complex (the respective lower valence state). Studies
have demonstrated that the reducing power of natural plant
extracts and EOs might be strongly correlated with their
antioxidant activities (Gulcin et al., 2012; Stratil et al., 2006;
Victoria et al., 2012).
Other important findings of our work are the effect of EOA
in the lipid peroxidation in the assays of SNP-induce linoleic
acid oxidation, in the SNP-induced lipid peroxidation in brain
structures, reduced the basal lipid peroxidation in the liver,
kidney, and brain, and when orally administered, reduced the
levels of MDA in liver, kidney, and brain of mice. Excessive
production of free radicals can generate a lipid peroxidation
chain reaction, which are responsible for many pathological
disorders (Castro et al., 2009).
According to Choi et al. (2002), the inhibition of linoleic
acid peroxidation by natural products is effective because of
the presence of various phytochemicals, such as phenolic
compounds, amino acids, ascorbic acid, tocopherols, and
pigments that might contribute to some antioxidant activity
singly or in combination.
Recently our research group demonstrated the effect
of another EO of the Myrtaceae family, the EO of
Eugenia uniflora L. leaves, in lipid peroxidation (Victoria
Table 1. Effect of acute treatment of EOA on catalase activity and ascorbic acid and NPSH levels.
Catalase (U CAT/mg protein) Ascorbic acid (mg AA/g tissue) NPSH (nmol NPSH/g tissue)
Dose (mg/kg) Liver Kidney Brain Liver Kidney Liver Kidney
0 (control) 0.87 ± 0.85 2.21 ± 0.41 0.25 ± 0.03 746.70 ± 2.20 734.30 ± 1.62 17 669.00 ± 1064.00 9122.00 ± 281.50100 0.88 ± 0.25 1.38 ± 0.47 0.24 ± 0.04 747.70 ± 2.40 733.10 ± 1.59 17 549.00 ± 694.50 9300.00 ± 174.00200 0.84 ± 0.30 1.91 ± 0.29 0.22 ± 0.03 747.30 ± 2.70 735.80 ± 1.89 18 191.00 ± 898.50 9004.00 ± 554.70500 0.70 ± 0.17 2.30 ± 0.60 0.23 ± 0.03 744.00 ± 2.20 736.10 ± 2.36 20 830.00 ± 900.50 10 251.00 ± 300.20
The values were analyzed by a one-way ANOVA, each value is expressed as the mean ± SE (n¼ 5).
Table 2. Evaluation of the antifungal activity of EOA against fungalstrains.
Fungal strainMinimum inhibitory concentration (mg/ml)
EOA Fluconazole
C. lipolytica 125.00 ± 00.00 62.50 ± 00.00C. parapsilosis 104.20 ± 36.08 52.10 ± 18.00C. guilhermondi 125.00 ± 00.00 62.50 ± 00.00C. albicans 166.70 ± 72.17* 62.40 ± 00.00T. asahi 41.67 ± 18.04 83.30 ± 36.10
The values were analyzed by a one-way ANOVA followed by theNewman–Keuls multiple comparison test, each value is expressed asthe mean ± SE. The tests were performed three times in duplicate.Asterisks represent significant effects (*p50.01) compared withfluconazole, for each strain.
DOI: 10.3109/13880209.2014.914231 Essential oil of araca 7
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
et al., 2013). Since the chemical composition of both EOs
(P. cattleianum and E. uniflora) revealed sesquiterpenes as
major compounds, we can infer that the presence of these
compounds can be related with the effect of EOs in lipid
peroxidation. Sesquiterpenes are formed from the assembly of
three isoprene units (C15). The extension of the chain
increases the number of cyclizations which allows a great
variety of structures (Bakkali et al., 2008).
In order to evaluate the possible toxic effect of EOA, mice
were orally treated with different doses of EOA. The results
demonstrated that the EOA did not present any signal of
toxicity. The tissues of animals were used to evaluate the
effect of EOA in some oxidative parameters, like TBARS,
CAT activity, and ascorbic acid levels. According to the
results, the levels of MDA were significantly reduced in liver,
kidney, and brain. MDA, one of the products of lipid
peroxidation, is malondialdehyde, which can be determined
by measuring the amount of TBA reactive species (Reznick &
Packer, 1994). According to many authors, lipid peroxidation
is involved in neurodegenerative disorders like Huntington
disease, amyotrophic lateral sclerosis, and Alzheimer disease.
The activity of catalase, an enzymatic defense, and the
levels of ascorbic acid and NPSH, a non-enzymatic defense,
are considered markers of oxidative stress, and a decrease in
its content might indicate an increase in oxidative stress.
In this work, the activity of catalase and the levels of ascorbic
acid were not changed by the administration of EOA, based
on this information it is possible suggest that EOA, orally
administered did not induced oxidative stress. Indeed, taken
together these data with results of lipid peroxidation, EOA
reduced the oxidative stress in mice at the tested doses.
Plants are rich in a wide variety of secondary metabolites,
such as phenols, terpenoids, sesquiterpenes, hydrocarbons,
flavonoids, tannins, acids, alcohols, aldehydes, and alkaloids,
which have been found to have antimicrobial properties in
in vitro studies. In addition, minor components play an
important part for antimicrobial activity, possibly by
producing a synergistic effect between other components.
Especially EOs, the aromatic oily liquid, are responsible for
antimicrobial activities of medicinal plants, which is effective
against microbial deterioration. Supercritical fluid extracts,
methanol, and ethanol extracts, and water extracts are also
utilized, but generally less effective (Skrovankova et al.,
2012).
EOA presents interesting effect in the inhibition of
important clinical fungal strains like T. asahii, C. para-
psilosis, C. albicans, C. lipolytica, and C. guilhermondi.
There are several studies that show that coriander, celery, and
sweet basil EO have an inhibitory effect on the growth of
yeasts (Matasyoh et al., 2008). Although the EOs showed
antimicrobial activity, the reason behind this capacity is not
well documented. This antimicrobial activity could be caused
by the major compounds of the EOs or due to a synergistic
effect between the major compounds and the minor ones
(Carovic-Stanko et al., 2010).
Possible mechanisms by which mycelial growth may be
reduced or totally inhibited have been proposed. Thus, Lucini
et al. (2006) indicated mycelial growth inhibition is caused by
the monoterpenes present in the EOs. These components
could increase the concentration of lipidic peroxides such as
hydroxyl, alkoxyl, and alkoperoxyl radicals, which leads to
cell death. According to Sharma and Tripathi (2006), the EOs
would act on the hypha of the mycelium, provoking exit of
components from the cytoplasm, the loss of rigidity, and
integrity of the hypha cell wall, resulting in its collapse and
death of the mycelium.
Conclusion
The EOA showed antioxidant activity and presented a LD50
higher than 500 mg/kg in mice. EOA demonstrated anti-
microbial activity against fungal strains. Thus, based on the
promising results shown in this work, other pharmacological
studies will be performed with this EO.
Declaration of interest
All authors declare that there are no conflicts of interest. L.
S., D. S. A., and R. G. J. are recipients of CNPq fellowships.
This work was supported by CNPq (Grants 472644/2010-6),
CAPES (23038.008258/2011-93), and FAPERGS (PRONEX
10/0027-4, PqG 1012043).
References
Aebi H. (1984). Catalase in vitro. Meth Enzymol 105:121–7.Alvarenga FQ, Mota BCF, Leite MN, et al. (2013). In vivo analgesic
activity, toxicity and phytochemical screening of the hydroalcoholicextract from the leaves of Psidium cattleianum Sabine.J. Ethnopharmacol 150:280–4.
Amensour M, Sendra E, Abrini J, et al. (2009). Total phenolic contentand antioxidant activity of myrtle (Myrtus communis) extracts. NatProd Commun 4:819–24.
Amorim AC, Lima CK, Hovell AM, et al. (2009). Antinociceptive andhypothermic evaluation of the leaf essential oil and isolated terpenoidsfrom Eugenia uniflora L. (Brazilian Pitanga). Phytomedicine 16:923–8.
Bakkali F, Averbeck S, Averbeck D, Idaomar M. (2008). Biologicaleffects of essential oils � A review. Food Chem Toxicol 46:446–75.
Brighenti FL, Gaetti-Jardim E, Danelon M, et al. (2012). Effect ofPsidium cattleianum leaf extract on enamel demineralisation anddental biofilm composition in situ. Arch Biol 57:1034–40.
Carovic-Stanko K, Orlic S, Politeo O, et al. (2010). Composition andantibacterial activities of essential oils of seven Ocimum taxa. FoodChem 119:196–201.
Castro MR, Lima JV, Freitas DP, et al. (2009). Behavioral and neurotoxiceffects of arsenic exposure in zebrafish (Danio rerio, Teleostei:Cyprinidae). Comp Biochem Physiol C Toxicol Pharmacol 150:337–42.
Chalannavar RK, Narayanaswamy VK, Baijnath H, Odhav B. (2013).Chemical constituents of the essential oil from leaves of Psidiumcattleianum var. cattleianum. J Med Plants Res 7:783–9.
Choi CW, Kim SC, Hwang SS, et al. (2002). Antioxidant activity andfree radical scavenging capacity between Korean medicinal plants andflavonoids by assay-guided comparison. Plant Sci 163:1161–8.
Drehmer AMF, Amarante CVTD. (2008). Post harvest preservation ofred strawberry–guavas as affected by maturity stage and storagetemperature. Rev Bras Frutic 30:322–6.
Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem 82:70–6.Folmer V, Bolzan RC, Farina M, et al. (2005). Mechanism of delta-
aminolevulinate dehydratase inhibition by phenyl selenoacetyleneinvolves its conversion to diphenyl diselenide. Toxicology 206:403–11.
Galho AS, Lopes NF, Bacarin MA, Lima MDGDS. (2007). Composicaoquımica e respiratorio de crescimento em frutos de Psidiumcattleyanum sabine durante o ciclo de desenvolvimento. Rev BrasFrutic 29:61–6.
Gulcin I. (2012). Antioxidant activity of food constituents: An overview.Arch Toxicol 86:345–91.
Jacques-Silva MC, Nogueira CW, Broch LC, et al. (2001). Diphenyldiselenide and ascorbic acid changes deposition of selenium and
8 M. R. Castro et al. Pharm Biol, Early Online: 1–9
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.
ascorbic acid in liver and brain of mice. Pharmacol Toxicol 88:119–25.
Lapcik O, Klejdus B, Kokoska L, et al. (2005). Identification ofisoflavones in Acca sellowiana and two Psidium species (Myrtaceae).Biochem Syst Ecol 33:983–92.
Liyana-Pathirana CM, Shahidi F. (2006). Antioxidant properties ofcommercial soft and hard winter wheats (Triticum aestivum L.) andtheir milling fractions. J Sci Food Agricult 86:477–85.
Lowry OH, Rosemburg NJ, Farr AL, Roudall R. (1951). Proteinmeasurement with Folin-Phenol reagent. J Biol Chem 193:265–75.
Lucini EI, Zunin MP, Lopez ML, Zygadlo JA. (2006). Effect ofmonoterpenes on lipid composition and sclerotial development ofSclerotium cepivorum Berk. J Phytopathol 154:441–6.
Luximon-Ramma A, Bahorun T, Crozier A. (2003). Antioxidant actionsand phenolic and vitamin C contents of common Mauritian exoticfruits. J Sci Food Agric 83:496–502.
Matasyoh LG, Matasyoh JC, Wachira FN, et al. (2008). Antimicrobialactivity of essential oils of Ocimum gratissimum L. from differentpopulations of Kenya. Afr J Tradit Complement Altern Med 5:187–93.
Medina AL, Haas LIR, Chaves FC, et al. (2011). Araca (Psidiumcattleianum Sabine) fruit extracts with antioxidant and antimicrobialactivities and antiproliferative effect on human cancer cells.Food Chem 128:916–22.
Moona JY, Mosaddika A, Kima H, et al. (2012). The chloroform fractionof guava (Psidium cattleianum Sabine) leaf extract inhibits humangastric cancer cell proliferation via induction of apoptosis. Food Chem125:369–75.
National Committee of Clinical Laboratory Standards (NCCLS). (2002).In: National Committee for Clinical Laboratory Standards. Referencemethod for broth dilution antifungal susceptibility testing of yeasts:Proposed standard. M27-A2.
Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animaltissues by thiobarbituric acid reaction. Anal Biochem 95:351–8.
Ozen T, Demirtas I, Aksit H. (2011). Determination of antioxidantactivities of various extracts and essential oil compositions of Thymuspraecox subsp. skorpilii var. skorpilii. Food Chem 124:58–64.
Pereira MC, Steffens RS, Jablonski A, et al. (2013). Characterization,bioactive compounds and antioxidant potential of three Brazilianfruits. J Food Comp Anal 29:19–24.
Pino JA, Marbot R, Vazquez C. (2001). Characterization of volatiles instrawberry guava (Psidium cattleianum Sabine) fruit. J Agric FoodChem 49:5883–7.
Re R, Pellegrini N, Proteggente A, et al. (1999). Antioxidant activityapplying an improved ABTS radical cation decolorization assay.Free Radic Biol Med 26:1231–7.
Reznick AZ, Packer L. (1994). Oxidative damage to proteins: spectro-photometric method for carbonyl assay. Methods Enzymol 233:357–63.
Sassa S. (1982). delta-Aminolevulinic acid dehydratase assay. Enzyme28:133–45.
Skrovankova S, Misurcova L, Machu L. (2012). Antioxidant activity andprotecting health effects of common medicinal plants. Adv Food NutrRes 67:75–139.
Sharma N, Tripathi A. (2006). Fungitoxicity of the essential oil of Citrussinensis on post-harvest pathogens. World J Microbiol Biotechnol22:587–93.
Singh C, Singh S, Pande C, et al. (2013). Exploration of antimicrobialpotential of essential oils of Cinnamomum glanduliferum, Feroniaelephantum, Bupleurum hamiltonii and Cyclospermum leptophyllumagainst foodborne pathogens. Pharm Biol 51:1607–10.
Solorzano-Santos F, Miranda-Novales MG. (2012). Essential oils fromaromatic herbs as antimicrobial agents. Curr Opinion Biotechnol23:136–4.
Stratil P, Klejdus B, Kuban V. (2006). Determination of total content ofphenolic compounds and their antioxidant activity in vegetablesevaluation of spectrophotometric. Meth J Agric Food Chem 54:607–16.
Stefanakis MK, Touloupakis E, Anastasopoulos E, et al. (2013).Antibacterial activity of essential oils from plants of the genusOriganum. Food Control 34:539–46.
Victoria FN, Brahm AS, Savegnago L, Lenardao EJ. (2013).Involvement of serotoninergic and adrenergic systems on theantidepressant-like effect of E. uniflora L. leaves essential oiland further analysis of its antioxidant activity. Neurosci Lett 544:105–9.
Victoria FN, Lenardao EJ, Savegnago L, et al. (2012). Essential oil of theleaves of Eugenia uniflora L.: Antioxidant and antimicrobial proper-ties. Food Chem Toxicol 50:2668–74.
Viuda-Martos M, Ruiz-Navajas Y, Fernandez-Lopez J, Perez-Alvarez J.(2008). Antifungal activity of lemon (Citrus lemon L.), mandarin(Citrus reticulata L.), grapefruit (Citrus paradisi L.) and orange(Citrus sinensis L.) essential oils. Food Control 19:1130–8.
Wang C, Yuan H, Bao X, Lan M. (2013). In vitro antioxidant andcytotoxic properties of ethanol extract of Alpinia oxyphylla fruits.Pharm Biol 51:1419–25.
DOI: 10.3109/13880209.2014.914231 Essential oil of araca 9
Phar
mac
eutic
al B
iolo
gy D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y U
nive
rsity
of
Was
hing
ton
on 1
2/02
/14
For
pers
onal
use
onl
y.